Navigation Links
Proposed $350 Million Class Action Settlement Regarding Drug Pricing Provides Consumers and Third-Party Payors With Money Back
Date:4/23/2009

WASHINGTON, April 23 /PRNewswire-USNewswire/ -- The United States District Court for the District of Massachusetts has preliminarily approved the settlement of a class action with McKesson, a large drug wholesaler. The lawsuit, called New England Carpenters Health Benefits Fund v. First DataBank, Inc., concerns the pricing of more than 450 brand-name drugs, and consumers and Third-Party Payors ("TPPs") could get money back.

Prescription drugs are often priced using certain benchmarks. The most common pricing benchmark is sometimes called the Average Wholesale Price, or "AWP." AWP is often used in determining how much insurance companies will reimburse for these prescription drugs and the co-payment price that some consumers pay for them. The lawsuit claims that two Defendants, McKesson and First DataBank, a publisher of drug data, wrongfully inflated the mark-up factor used to determine the AWP of over 450 drugs. The lawsuit alleges that, as a result, many drug purchasers overpaid for these drugs. FDB and McKesson deny any wrongdoing.

McKesson has agreed to settle the claims against it and will pay a total of $350 million into a Settlement Fund to benefit a class of consumers and non-governmental Third-Party Payors with up to $60 million allocated to consumer Class Members alone.

Included in the McKesson Proposed Settlement are consumers who paid percentage co-payments for any of the settlement drugs between August 2, 2001 and March 15, 2005; uninsured or underinsured consumers who paid the cash price of any of the settlement drugs between August 1, 2001 and January 23, 2009; and TPPs that paid or reimbursed for all or a part of the cost of any settlement drug from August 2001 to March 15, 2005. TPPs include, but are not limited to, insurance companies, health plans, union health and welfare plans, and self-insured employers.

Potential members of the class of TPPs and consumers who paid a percentage co-payment were previously notified of the pending trial against McKesson and had until November 15, 2008 to exclude themselves from the Class. Class Members who did not exclude themselves are included in the Proposed Settlement and will be bound by the Court's rulings. Uninsured or underinsured consumers who paid the cash price of settlement drugs may exclude themselves and will not get money back but will keep their rights to sue McKesson at their own expense. A request for exclusion must be in writing by June 8, 2009. The Court will determine whether to approve the McKesson Proposed Settlement at a Fairness Hearing on July 23, 2009 at 2 p.m.

"The McKesson Proposed Settlement will allow consumers and TPPs to receive some money back in the near future if they file a claim," said Steve W. Berman of Hagens Berman Sobol Shapiro LLP, Counsel for the Plaintiffs in this case.

For detailed information and a list of all the drugs included, call toll-free 1-877-625-9414, visit www.AWPClassActions.com, email info@AWPClassActions.com or write: McKesson Settlement Administrator c/o Rust Consulting, Inc, PO Box 24607, West Palm Beach, FL 33416.


'/>"/>
SOURCE McKesson Settlement Administrator
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Avoiding No Mans Land: New Deloitte Study on Follow-on Biologics Investigates Proposed Legislation and Possible Unintended Consequences
2. White House Protest Denouncing Obamas Speech at Notre Dame and Proposed Change in Abortion Conscience Regs.
3. Proposed Settlement Will Make Up to $28 Million Available to Individuals Who Purchased and Companies That Reimbursed for Paxil CR(R)
4. American College of Surgeons Supports Steps to Shore Up Medicare Payment System In Proposed Federal Budget
5. MGT Capital Investments, Inc.: Failure to Satisfy a Continued Listing Rule Based on a Lack of Shareholder Meeting in 2008 and Medicsight Statement Regarding CMS Proposed Decision
6. Advocates Call on Legislature to Stop Proposed Rx Cuts to the Elderly and Poor
7. Courage Center Experts Disagree With Gov. Pawlentys Proposed Budget Cuts
8. Endocare Announces Filing of Form S-4 Registration Statement Related to Proposed Merger With Galil Medical
9. Johnson & Johnson Announces Satisfaction of Regulatory Clearances Condition for its Proposed Acquisition of Mentor Corporation
10. Healthcare Organizations Launch Collaborative Initiative to Test HIPAA Transactions Against Proposed 5010 Standards
11. Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology: